ocular surface diseases
Recently Published Documents


TOTAL DOCUMENTS

171
(FIVE YEARS 74)

H-INDEX

21
(FIVE YEARS 5)

2022 ◽  
Vol 100 (S267) ◽  
Author(s):  
Itzel Aguilar‐Valdez ◽  
Paola De La Parra‐Colin ◽  
Jesús Luna‐Briceño

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Li-Ju Lai ◽  
Vincent Chin-Hung Chen ◽  
Yao-Hsu Yang ◽  
Kai-Liang Kao ◽  
Ko-Jung Chen ◽  
...  

AbstractWhether patients with Mycoplasma infection have an increased risk of ocular surface ulcers. Using a nation-wide database, we identified patients with a new diagnosis of Mycoplasma infection between 1997 and 2013, and compared them with age-, sex-, and index year-matched subjects without the infection. Cox proportional regression was performed to compare the risk of corneal diseases between the two cohorts. The incidence of corneal diseases was significantly higher in the 4223 patients with Mycoplasma infection than in the 16,892 patients without (7.28 vs. 5.94 per 1000 person-years, P < 0.01). The adjusted hazard ratio for the risk of corneal diseases in the study cohort was 1.21 times higher (95% CI 1.02–1.44) than that in the comparison cohort. Mycoplasma infection might be a predisposing factor for patients with keratitis.


2021 ◽  
Vol 22 ◽  
pp. 242-244
Author(s):  
Susan Erickson ◽  
Amy Gallant Sullivan ◽  
Juan Carlos Abad ◽  
Monica Alves ◽  
Stefano Barabino ◽  
...  

2021 ◽  
Vol 22 (19) ◽  
pp. 10386
Author(s):  
Yongseok Mun ◽  
Jin Sun Hwang ◽  
Young Joo Shin

The ocular surface is a gateway that contacts the outside and receives stimulation from the outside. The corneal innate immune system is composed of many types of cells, including epithelial cells, fibroblasts, natural killer cells, macrophages, neutrophils, dendritic cells, mast cells, basophils, eosinophils, mucin, and lysozyme. Neutrophil infiltration and degranulation occur on the ocular surface. Degranulation, neutrophil extracellular traps formation, called NETosis, and autophagy in neutrophils are involved in the pathogenesis of ocular surface diseases. It is necessary to understand the role of neutrophils on the ocular surface. Furthermore, there is a need for research on therapeutic agents targeting neutrophils and neutrophil extracellular trap formation for ocular surface diseases.


2021 ◽  
Vol 10 (18) ◽  
pp. 4248
Author(s):  
Daniel Duck-Jin Hwang ◽  
Seok-Jae Lee ◽  
Jeong-Hun Kim ◽  
Sang-Mok Lee

Neuropeptides are known as important mediators between the nervous and immune systems. Recently, the role of the corneal nerve in the pathogenesis of various ocular surface diseases, including dry eye disease, has been highlighted. Neuropeptides are thought to be important factors in the pathogenesis of dry eye disease, as suggested by the well-known role between the nervous and immune systems, and several recently published studies have elucidated the previously unknown pathogenic mechanisms involved in the role of the neuropeptides secreted from the corneal nerves in dry eye disease. Here, we reviewed the emerging concept of neurogenic inflammation as one of the pathogenic mechanisms of dry eye disease, the recent results of related studies, and the direction of future research.


2021 ◽  
Vol 8 ◽  
Author(s):  
Darren Shu Jeng Ting ◽  
Jessica Cairns ◽  
Bhavesh P. Gopal ◽  
Charlotte Shan Ho ◽  
Lazar Krstic ◽  
...  

Background/Aim: To examine the risk factors, clinical characteristics, outcomes, and prognostic factors of bacterial keratitis (BK) in Nottingham, UK.Methods: This was a retrospective study of patients who presented to the Queen's Medical Centre, Nottingham, with suspected BK during 2015–2019. Relevant data, including the demographic factors, risk factors, clinical outcomes, and potential prognostic factors, were analysed.Results: A total of 283 patients (n = 283 eyes) were included; mean age was 54.4 ± 21.0 years and 50.9% were male. Of 283 cases, 128 (45.2%) cases were culture-positive. Relevant risk factors were identified in 96.5% patients, with ocular surface diseases (47.3%), contact lens wear (35.3%) and systemic immunosuppression (18.4%) being the most common factors. Contact lens wear was most commonly associated with P. aeruginosa whereas Staphylococci spp. were most commonly implicated in non-contact lens-related BK cases (p = 0.017). At presentation, culture-positive cases were associated with older age, worse presenting corrected-distance-visual-acuity (CDVA), use of topical corticosteroids, larger epithelial defect and infiltrate, central location and hypopyon (all p &lt; 0.01), when compared to culture-negative cases. Hospitalisation was required in 57.2% patients, with a mean length of stay of 8.0 ± 8.3 days. Surgical intervention was required in 16.3% patients. Significant complications such as threatened/actual corneal perforation (8.8%), loss of perception of light vision (3.9%), and evisceration/enucleation (1.4%) were noted. Poor visual outcome (final corrected-distance-visual-acuity of &lt;0.6 logMAR) and delayed corneal healing (&gt;30 days from initial presentation) were significantly affected by age &gt;50 years, infiltrate size &gt;3 mm, and reduced presenting vision (all p &lt; 0.05).Conclusion: BK represents a significant ocular morbidity in the UK, with ocular surface diseases, contact lens wear, and systemic immunosuppression being the main risk factors. Older age, large infiltrate, and poor presenting vision were predictive of poor visual outcome and delayed corneal healing, highlighting the importance of prevention and early intervention for BK.


2021 ◽  
Vol 8 ◽  
Author(s):  
Hon Shing Ong ◽  
John K. Dart ◽  
Jodhbir S. Mehta

Cicatricial conjunctival diseases (CCDs), are a diverse group of ocular surface diseases characterized by chronic scarring of the conjunctiva. These diseases can cause significant ocular morbidity. They are life-long once acquired and can be debilitating, painful diseases leading to visual loss. A recent international consensus of ocular surface disease experts have placed emphasis on the need of validated clinical disease scoring systems for CCDs, important for the objective evaluation of disease severity, outcomes of therapies, and longitudinal monitoring of disease. This review aims to describe the various published clinical disease scoring systems available for CCDs and evaluates the benefits and limitations of each system. It can be used as a guide for clinicians managing patients with CCDs and for researchers evaluating potential therapies in clinical trials.


Sign in / Sign up

Export Citation Format

Share Document